ADA Scientific Sessions 2025 Abstract

Long-Term (24-Month) Follow-up of Indian T2DM Patients on Oral Semaglutide

By Supratik Bhattacharyya

Study in peopleInterventions

The paper

Supratik Bhattacharyya

Kolkata

ADA Scientific Sessions 2025 Abstract, 13 Jun 2025

Presented at ADA Scientific Sessions 2025, poster 764-P

doi.org/10.2337/db25-764-p

The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Nature Medicine4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes